Covestor
RPRX icon

Covestor’s Royalty Pharma RPRX Stock Holding History

Covestor’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$79K Hold
1,359
– – 0.05% 486
2026
Q2 		$76K Sell
1,359
-681
-33% -$35.4K 0.04% 532
2026
Q1 		$98K Sell
2,040
-1,900
-48% -$83.2K 0.07% 299
2025
Q4 		$152K Buy
3,940
+162
+4% +$6.18K 0.08% 334
2025
Q3 		$133K Sell
3,778
-14
-0.4% -$507 0.07% 404
2025
Q2 		$137K Sell
3,792
-3,665
-49% -$121K 0.08% 374
2025
Q1 		$232K Sell
7,457
-542
-7% -$17.2K 0.15% 111
2024
Q4 		$204K Sell
7,999
-327
-4% -$8.67K 0.13% 168
2024
Q3 		$236K Sell
8,326
-1,331
-14% -$36.9K 0.15% 126
2024
Q2 		$255K Buy
9,657
+941
+11% +$26.1K 0.17% 98
2024
Q1 		$265K Buy
8,716
+6,139
+238% +$181K 0.17% 75
2023
Q4 		$72K Buy
2,577
+1,348
+110% +$37K 0.05% 689
2023
Q3 		$33K Buy
1,229
+221
+22% +$6.56K 0.02% 943
2023
Q2 		$31K Sell
1,008
-1,716
-63% -$58.1K 0.02% 979
2023
Q1 		$98K Buy
2,724
+758
+39% +$28.1K 0.09% 383
2022
Q4 		$78K Buy
1,966
+67
+4% +$2.8K 0.06% 531
2022
Q3 		$76K Buy
1,899
+1,892
+27,029% +$80.8K 0.07% 509
2022
Q2 		$0 Sell
7
-6
-46% -$246 ﹤0.01% 2293
2022
Q1 		$1K Sell
13
-1
-7% -$39 ﹤0.01% 1931
2021
Q4 		$1K Buy
+14
New +$544 ﹤0.01% 1906

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Covestor's RPRX Position: Q3 2026 in Review

Covestor held its Royalty Pharma (RPRX) position steady in Q3 2026 at 1,359 shares worth $79K. The position accounts for 0.05% of the portfolio, ranked #486.

Covestor first reported a position in RPRX in Q4 2021 and has held it in 20 quarters since. The position peaked at $265K in Q1 2024. 573 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Covestor held 1,359 shares of Royalty Pharma worth $79K as of Q3 2026.
  • Covestor left its Royalty Pharma share count unchanged in Q3 2026.
  • Royalty Pharma made up 0.05% of Covestor's portfolio in Q3 2026, its #486 holding.
  • Covestor first reported a position in Royalty Pharma in Q4 2021 and has held it in 20 quarters since.
  • Covestor's Royalty Pharma position peaked at $265K in Q1 2024.
  • 573 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.